Remove 2001 Remove Pharmaceuticals Remove Pharmacy
article thumbnail

Manitoba Judge’s Opinion Reveals Different Side of the CanadaDrugs Case

Policy Prescription

It’s important because this case was wrongly used as a pretext to oppose safe personal drug importation and international online pharmacies, which help Americans afford prescription drugs. Kris Thorkelson never pled guilty to selling counterfeit drugs. supply chain.

article thumbnail

Analysis Life Sciences Thank You The cost of artificially short expiration dates: Worsened shortages, higher costs and more waste

Agency IQ

In 2001, the American Medical Association (AMA) conducted a survey of relevant stakeholders – including PhRMA, the U.S. Pharmacopeia (USP) and the FDA – to clarify whether the “actual ‘shelf life’ of many pharmaceutical products might be considerably longer than the expiration date that appears on the manufacturer’s container.”

Science 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article EMA Thank You New EC report dives deep to better understand shortages of critical medicines

Agency IQ

The Commission’s communication was accompanied by a Q&A document defining key terms and ideas, including how the effort was related to ongoing efforts to overhaul the pharmaceuticals legislation. active pharmaceutical ingredient, fill/finish, packaging/labeling). reducing the frequency of a dose) or pharmaceutical form (e.g.,

article thumbnail

Another RICOdiculous Decision

Drug & Device Law

We’ve discussed recently how a federal statute intended to allow suits against international terrorists has been misapplied as allowing suits against pharmaceutical companies. Takeda Pharmaceuticals Co. , 341 (2001). Takeda Pharmaceutical Co. , the relationship between [plaintiff] and its pharmacy benefit manager. . .

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

151, 163-68 (2001)) (lengthy discussion of FDA regulatory process omitted). The court in Wolfe refused to impose a negligence duty on the defendant pharmaceutical company to develop and obtain FDA approval of the plaintiff’s non-FDA-approved alternative. This would run counter to. . . 2d at 571.

FDA 59
article thumbnail

FDA’s Rules are FDA’s to Enforce

Drug & Device Law

341 (2001). Similarly, the court in Nexus Pharmaceuticals, Inc. Central Admixture Pharmacy Services, Inc., A provision that has been enforced and reinforced in the courts for at least the last 22 years when the Supreme Court decided Buckman Co. Plaintiffs’ Legal Comm. , See Telebrands , at *8-11. 48 F4th 1040, 1049 (9 th Cir.